Special Issue "Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery II"
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 15379
A printed edition of this Special Issue is available here.
Interests: opioid receptors; opioid pharmacology; pain research; CNS disorders; opioid drug discovery; structure-activity-relationships; GPCRs signalling
Special Issues, Collections and Topics in MDPI journals
Special Issue in Molecules: Recent Contributions of Female Scientists to the Advancement of Medicinal Chemistry
Special Issue in Molecules: Exclusive Papers from the Editorial Board Members (EBMs) of the Section “Medicinal Chemistry” of Molecules
Topics: Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery
Interests: opioids; opioid pharmacology; substance use disorders; pain and anxiety disorders; preclinical drug discovery
Following the successful first edition of the Special Issue “Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery” (https://www.mdpi.com/journal/molecules/special_issues/Opioid_Drug), the second edition of this Special Issue aims to gather works on the latest chemical and pharmacological developments in opioid research, with further understanding of opioids and opioid receptor-mediated actions and the search for alternative treatments for pain and other human disorders where the opioid system plays an central role. A special attention is drawn to advancing concepts in opioid drug discovery in the light of the current opioid crisis. Studies investigating interactions between the opioid system and coronavirus disease 2019 (COVID-19) will also be suitable for this Special Issue.
We give thanks for past contributions and look forward to receiving new contributions as original articles, short communications, and reviews on the challenging aspects of the opioid research field, ranging from basic science to translational research.
Prof. Dr. Mariana Spetea
Prof. Dr. Richard M. van Rijn
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2300 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Opioid receptors
- Opioids drugs
- Opioid epidemic
- Natural and synthetic compounds
- Small molecules and peptides
- Agonists, antagonists, and partial agonists
- Biased agonists and allosteric modulators
- Multifunctional and bivalent ligands
- Drug design
- Synthesis and analytics
- Molecular docking and dynamics simulations
- Structure–activity relationships
- CNS disorders
- Cardiac ischemia
- Gastrointestinal disorders
- Signal transduction
- Opioid side effects